Влияние антигипертензивной терапии на показатели жесткости сосудистой стенки как на фактор риска развития сердечно-сосудистых заболеваний


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Доступ платный или только для подписчиков

Аннотация

Показатели жесткости стенки артерий важный фактор, отражающий риск развития сердечно-сосудистых заболеваний, в том числе артериальной гипертензии (АГ), и их прогноз. Влияние современных групп антигипертензивных лекарственных средств на показатели жесткости артериальной стенки важно учитывать, поскольку оно потенциально связано со снижением риска развития кардиоваскулярных осложнений и улучшением прогноза у больных АГ.

Полный текст

Доступ закрыт

Об авторах

Ю. Гущина

Российский университет дружбы народов

Email: gushchina@mail.ru
кандидат фармацевтических наук Москва

Список литературы

  1. Шальнова С.А., Деев А.Д. Ишемическая болезнь сердца в России: распространенность и лечение (по данным клинико-эпидемиологических исследований) // Тер. арх. 2011; 1: 7-12.
  2. Duprez D., Jacobs D. Jr, Lutsey P. et al. Association of small artery elasticity with incident cardiovascular disease in older adults: The multi-ethnic study of atherosclerosis // Am. J. Epidemiol. 2011; 174: 528-36.
  3. Laurent S. et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications // Eur. Heart. J. 2006; 27 (21): 2588-605.
  4. Van der Heijden-Spek J., Staessen J., Fagard R. et al. Effect of age on brachial artery wall properties differs from the aorta and is gender dependent: a population study // Hypertension. 2000; 35 (2): 637-42.
  5. Бойцов С.А. Сосуды как плацдарм и мишень артериальной гипертонии // Болезни сердца и сосудов. 2006; 1 (3): 36.
  6. McEniery C., Wilkinson I., Avolio A. Age, hypertension and arterial function // Clin. Exp. Pharmacol. Physiol. 2007; 34 (7): 665-71.
  7. Орлова Я.А., Агеев Ф.Т. Жесткость артерий как интегральный показатель сердечно-сосудистого риска: физиология, методы оценки и медикаментозной коррекции // Сердце. 2006; 5 (2): 65-70.
  8. Жирнова О.А., Берестень Н.Ф., Пестовская О.Р. и др. Неинвазивная диагностика нарушения эластических свойств артериальных сосудов // Эл. журн. ANGIOLOGIA.ru. 2011; 1.
  9. Zoungas S., Asmar R. Arterial stiffness and cardiovascular outcome // Clin. Exp. Pharmacol. Physiol. 2007; 34 (7): 647-51.
  10. Laurent S., Cockcroft J., Van Bortel L. et al. European Network for Noninvasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications // Eur. Heart. J. 2006; 27: 2588-605.
  11. Mancia G., De Backer G., Dominiczak A. et al. 2007 guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) // Eur. Heart. J. 2007; 28: 1462-536.
  12. Cameron J. Estimation of arterial mechanics in clinical practice and as a research technique // Clin. Exp. Pharmacol. Physiol. 1999; 26: 285-94.
  13. Safar M., Blacher J., Jankowski P. Arterial stiffness, pulse pressure,and cardiovascular disease is it possible to break the vicious circle? // Atherosclerosis. 2011; 218: 263-71.
  14. Laurent S., Cockcroft J., Van Bortel L. et al. European Network for Noninvasive Investigation of Large Arteries. Expert consensus documenton arterial stiffness: methodological issues and clinical applications // Eur. Heart. J. 2006; 27: 2588-605.
  15. Blacher J., Guerin A., Pannier B. et al. Impact of aortic stiffness on survival in end-stage renal disease // Circuletion. 1999; 99: 2434-9.
  16. Blacher J., Guerin A., Pannier B. et al. Impact of Aortic Stiffness on Survival in End stage renal disease // Circulation. 2001; 99: 2117-24.
  17. Shoji T., Emoto M., Shinohara K. et al. Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease // J. Am. Soc. Nephrol. -2001; 12: 2117-24.
  18. Laurent S., Boutouyrie P., Asmar R. et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients // Hypertension. 2001; 37 (5): 1236-41.
  19. London G., Blacher J., Pannier B. et al. Arterial wave reflections and survival in end stage renal failure // Hypertension. 2001; 38 (3): 434-8.
  20. Williams B., Lacy P., Cruickshank J. et al. Impact of statin therapy on central aortic pressures and hemodynamics: principal results of the Conduit Artery Function Evaluation-Lipid-Lowering Arm (CAFE-LLA) Study // Circulation. 2009; 119: 53-61.
  21. After the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study: Implications for Fenofibrate Frank M. Sacks // Am. J. Cardiol. 2008; 102 (Suppl.): 34-40.
  22. Nichols W., O’Rourke M., Vlachopoulos C. ed. McDonald’s Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles, 6th ed. London: Hodder Arnold, 2011.
  23. The Reference Values for Arterial Stiffness Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: «establishing normal and reference values» // Eur. Heart. J. 2010; 31: 2338-50.
  24. Guerin A., Blacher J., Pannier B. et al. Impact of aortic stiffness attenuation on survival of patients in end stage renal failure // Circulation. 2001; 103 (7): 987-92.
  25. Cameron J., Asmar R., Struijker-Boudier H. et al. Current and future initiatives for vascular health management in clinical practice // Vascular Health and Risk Management. 2013; 9: 255-64.
  26. Safar M., Laurent S., Safavian A. et al. Sodium and large arteries in hypertension: effects of indapamide // Am. J. Med. 1988; 84: 15-9.
  27. Kool M., Lustermans F., Breed J. et al. The influence of perindopril and the diuretic combination amiloride plus hydrochlorothiazide on the vessel wall properties of large arteries in hypertensive patients // J. Hypertens. 1995; 13: 839-48.
  28. Mahmud A., Feely J. Effect of angiotensin II receptor blockade on arterial stiffness: beyond blood pressure reduction // Am. J. Hypertens. 2002; 15 (12): 1092-5.
  29. Benetos A., Lafleche A., Asmar R. et al. Arterial stiffness, hydrochlorothiazide and converting enzyme inhibition in essential hypertension // J. Hum. Hypertens. 1996; 10: 77-82.
  30. Girerd X., Giannattasio C., Moulin C. et al. Regression of radial artery wall hypertrophy and improvement of carotid artery compliance after long-term antihypertensive treatment: the Pericles study // J. Am. Coll. Cardiol. 1998; 31: 1064-73.
  31. Kelly R., Daley J., Avolio A. et al. Arterial dilatation and reduced wave reflection: benefit of dilevalol in hypertension // Hypertension. 1990; 14: 14-21.
  32. Asmar R., Kerihuel J., Girerd X. et al. Effect of bisoprolol on blood pressure and arterial hemodynamics in systemic hypertension // Am. J. Cardiol. 1991; 68: 61-4.
  33. Ting C., Chen C., Chang M. et al. Shortand Long-term effects of antihypertensive drugs on arterial reflections, compliance and impedance // Hypertension. 1995; 26 (3): 524-30.
  34. Asmar R., London G., O’Rourke M. et al. REASON Project Co-ordinators and Investigators. Improvement in blood pressure, arterial stiffness and wave reflections with a very low dose perindopril/indapamide combinaton in hypertensive patient: a comparison with atenolol // Hypertension. 2001; 38 (4): 922-6.
  35. Williams B., Lacy P., Thom S. et al. CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study // Circulation. 2006; 113: 1213-25.
  36. Asmar R., London G., O’Rourke M. et al. REASON Project Investigators. Amelioration of arterial properties with a perindopril-indapamide very low dose combination // J. Hypertens. 2001; 19 (4): 15-20.
  37. Barenbrock M. Effect of lisinopril and metoprolol on arterial distensibility // Hypertension. 2004; 24 (1): 161-3.
  38. De Cesaris R., Ranieri G., Filitti V. et al. Large artery compliance in essential hypertension. Effects of calcium antagonism and p-blocking // Am. J. Hypertens. -1992; 5: 624-8.
  39. Kampus P., Serg M., Kals J. et al. Differential effects of nebivolol and metoprolol on central aortic pressure and left wall thickness // Hypertension. -2011; 57 (6): 1122-8.
  40. Bouthier J., De Luca N., Safar M. et al. Cardiac hypertrophy and arterial distensibility in essential hypertension // Am. Heart J. 1985; 109: 1345-52.
  41. Pancera P., Arosio E., Arcaro G. et al. Haemodynamic parameters in hypertensive patients: changes induced by lacidipine and nifedipine // J. Hypertens. 1989; 7 (6): 284-5.
  42. Asmar R., Benetos A., Brahimi M. et al. Arterial and antihypertensive effects of nitrendipine: a double-blind comparison versus placebo // J. Cardiovasc. Pharm. 1992; 20: 858-63.
  43. Tedeschi C., Guarini P., Giodano G. et al. Effects of nicardipine on intimal-medial thickness and arterial distensibility in hypertensive patients // Int. Angiol. -1993; 12: 344-7.
  44. Asmar R., Benetos A., Chaouchi-Teyara K. et al. Comparison of effects of felodipine versus hydrochlorthiazide on arterial diameter and pulse wave velocity in essential hypertension // Am. J. Cardiol. 2003; 72: 794-8.
  45. Topouchian J., Asmar R., Sayegh F. et al. Changes in arterial structure and function under trandolapril-verapamil combination in hypertension // Stroke. -1999; 30: 1056-64.
  46. Li Y., Ma S., Du M. et al. Perindopril, amlodipine and telmisartan improve arterial stiffness in patients with hypertension // Zhonghua Xin Xue Guan Bing Za Zhi. 2009; 37 (10): 908-12.
  47. Mie Kurata, Takafumi Okura, Sanae Watanabe et al. Effects of amlodipine and candesartan on arterial stiffness estimated by cardio-ankle vascular index in patients with essential hypertension: A 24-week study // Cur. Ther. Res. 2008; 69: 412-22.
  48. Ting C., Chen C., Chang M. et al. Shortand Long-term effects of antihypertensive drugs on arterial reflections, compliance and impedance // Hypertension. 1995; 26 (3): 524-30.
  49. Shahin Y., Khan J. et al. Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: A meta-analysis and metaregression of randomised controlled trials // Atherosclerosis. 2012; 221: 18-33.
  50. Topouchian J., Brisac A., Pannier B. et al. Assessment of the acute arterial effects of converting enzyme inhibition in essential hypertension: a double-blind comparative and crossover study // J. Hum. Hypertens. 1998; 12: 181-7.
  51. Tsang T., Barnes M., Abhayaratna W. et al. Effects of quinapril on left atrial structural remodeling and arterial stiffness // Am. J. Cardiol. 2006; 97 (6): 916-20.
  52. Asmar R., Topouchian J., Pannier B. et al. Pulse wave velocity as end point in large-scale intervention trial. The Complior study. Scientific, Quality Control, Co-ordination and Investigation Committees of the Complior Study // J. Hypertens. 2001; 19 (4): 813-8.
  53. Mallareddy M., Parikh C., Peixoto A. Effect of angiotensin-converting enzyme inhibitors on arterial stiffness in hypertension: systematic review and meta-analysis // J. Clin. Hypertens (Greenwich). 2006; 8 (6): 398-403.
  54. Koumaras Ch., Tzimou M., Stavrinou E. et al. Role of Antihypertensive Drugs in Arterial «De-Stiffening» and Central Pulsatile Hemodynamics // Am. J. Cardiovasc. Drugs. 2012; 12 (3): 143-56.
  55. Asmar R. Effect of antihypertensive agents on arterial stiffness as evaluated by pulse wave velocity: clinical implications // Am. J. Cardiovasc. Drugs. 2001; 1: 387-97.
  56. Mahmud A., Feely J. Favourable effects on arterial wave reflection and pulse pressure amplification of adding angiotensin II receptor blockade in resistant hypertension // J. Hum. Hypertens. 2000; 14: 541-6.
  57. Asmar R. Effect of telmisartan on arterial distensibility and central blood pressure in patients with mild to moderate hypertension and Type 2 diabetes mellitus // J. Renin Angiotensin Aldost. Syst. 2001; (Suppl. 2): 8-11.
  58. Klingbeil A., John S., Schneider M. et al. AT-1 receptor blockade improves augmentation index: a double-blind, randomised, controlled study // J. Hypertens. -2002; 20 (12): 2423-8.
  59. Klemsdal T., Moan A., Kjeldsen S. Effects of selective angiotensin II Type 1 receptor blockade with losartan on arterial compliance in patients with mild essential hypertension // Blood Press. 1999; 8 (4): 214-9.
  60. Mahmud A., Feely J. Reduction in Arterial Stiffness with Angiotensin II antagonist is comparable with and additive to ACE inhibition // Am. J. Hypertens. -2002; 15: 321-5.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© ИД "Русский врач", 2013